Diminished flare response in neuropathic diabetic patients. Comparison of effects of substance P, histamine, and capsaicin.
Diabetes October 1987 36:1139-1143; doi:10.2337/diabetes.36.10.1139
Effect of IgG subclasses on in vivo bioavailability and metabolic fate of immune-complexed insulin in Lewis rats. Diabetes October 1987 36:1144-1151; doi:10.2337/diabetes.36.10.1144
Effects of tolazamide and exogenous insulin on pattern of postprandial carbohydrate metabolism in patients with non-insulin-dependent
diabetes mellitus. Results of randomized crossover trial. Diabetes October 1987 36:1130-1138; doi:10.2337/diabetes.36.10.1130
Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics. Diabetes October 1987 36:1195-1202; doi:10.2337/diabetes.36.10.1195
Effects of glucose and diabetes on binding of naloxone and dihydromorphine to opiate receptors in mouse brain. Diabetes October 1987 36:1173-1177; doi:10.2337/diabetes.36.10.1173
Effects of fasting on plasma glucose and prolonged tracer measurement of hepatic glucose output in NIDDM. Diabetes October 1987 36:1187-1194; doi:10.2337/diabetes.36.10.1187
Loss of early phase of insulin release in humans impairs glucose tolerance and blunts thermic effect of glucose. Diabetes October 1987 36:1167-1172; doi:10.2337/diabetes.36.10.1167
Diminished flare response in neuropathic diabetic patients. Comparison of effects of substance P, histamine, and capsaicin.
Diabetes October 1987 36:1139-1143; doi:10.2337/diabetes.36.10.1139
Identification and characterization of insulin receptors in basolateral membranes of dog intestinal mucosa. Diabetes October 1987 36:1124-1129; doi:10.2337/diabetes.36.10.1124
Effects of glucose and diabetes on binding of naloxone and dihydromorphine to opiate receptors in mouse brain. Diabetes October 1987 36:1173-1177; doi:10.2337/diabetes.36.10.1173
Effects of tolazamide and exogenous insulin on pattern of postprandial carbohydrate metabolism in patients with non-insulin-dependent
diabetes mellitus. Results of randomized crossover trial. Diabetes October 1987 36:1130-1138; doi:10.2337/diabetes.36.10.1130
Identification and characterization of insulin receptors in basolateral membranes of dog intestinal mucosa. Diabetes October 1987 36:1124-1129; doi:10.2337/diabetes.36.10.1124
Identification and characterization of insulin receptors in basolateral membranes of dog intestinal mucosa. Diabetes October 1987 36:1124-1129; doi:10.2337/diabetes.36.10.1124
Identification and characterization of insulin receptors in basolateral membranes of dog intestinal mucosa. Diabetes October 1987 36:1124-1129; doi:10.2337/diabetes.36.10.1124
Nutrition and somatomedin. XVII. Circulating somatomedin C during treatment of diabetic ketoacidosis. Diabetes October 1987 36:1152-1160; doi:10.2337/diabetes.36.10.1152
Effects of fasting on plasma glucose and prolonged tracer measurement of hepatic glucose output in NIDDM. Diabetes October 1987 36:1187-1194; doi:10.2337/diabetes.36.10.1187
Nutrition and somatomedin. XVII. Circulating somatomedin C during treatment of diabetic ketoacidosis. Diabetes October 1987 36:1152-1160; doi:10.2337/diabetes.36.10.1152
Effects of glucose and diabetes on binding of naloxone and dihydromorphine to opiate receptors in mouse brain. Diabetes October 1987 36:1173-1177; doi:10.2337/diabetes.36.10.1173
Adoptive transfer of insulitis and diabetes in neonates of diabetes-prone and -resistant rats. Tissue localization of injected
blasts. Diabetes October 1987 36:1116-1123; doi:10.2337/diabetes.36.10.1116
Subunit structure, autophosphorylation, and tyrosine-specific protein kinase activity of hepatic insulin receptors in fetal,
neonatal, and adult rats. Diabetes October 1987 36:1161-1166; doi:10.2337/diabetes.36.10.1161
Diminished flare response in neuropathic diabetic patients. Comparison of effects of substance P, histamine, and capsaicin.
Diabetes October 1987 36:1139-1143; doi:10.2337/diabetes.36.10.1139
Adoptive transfer of insulitis and diabetes in neonates of diabetes-prone and -resistant rats. Tissue localization of injected
blasts. Diabetes October 1987 36:1116-1123; doi:10.2337/diabetes.36.10.1116
Adoptive transfer of insulitis and diabetes in neonates of diabetes-prone and -resistant rats. Tissue localization of injected
blasts. Diabetes October 1987 36:1116-1123; doi:10.2337/diabetes.36.10.1116
Proinsulin-specific monoclonal antibodies. Immunocytochemical application as beta-cell markers and as probes for conversion.
Diabetes October 1987 36:1203-1211
Marsh, M
Effects of tolazamide and exogenous insulin on pattern of postprandial carbohydrate metabolism in patients with non-insulin-dependent
diabetes mellitus. Results of randomized crossover trial. Diabetes October 1987 36:1130-1138; doi:10.2337/diabetes.36.10.1130
Effect of IgG subclasses on in vivo bioavailability and metabolic fate of immune-complexed insulin in Lewis rats. Diabetes October 1987 36:1144-1151; doi:10.2337/diabetes.36.10.1144
Prolactin enhances cell-to-cell communication among beta-cells in pancreatic islets. Diabetes October 1987 36:1098-1103; doi:10.2337/diabetes.36.10.1098
Prolactin enhances cell-to-cell communication among beta-cells in pancreatic islets. Diabetes October 1987 36:1098-1103; doi:10.2337/diabetes.36.10.1098
Nutrition and somatomedin. XVII. Circulating somatomedin C during treatment of diabetic ketoacidosis. Diabetes October 1987 36:1152-1160; doi:10.2337/diabetes.36.10.1152
Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics. Diabetes October 1987 36:1195-1202; doi:10.2337/diabetes.36.10.1195
Effects of tolazamide and exogenous insulin on pattern of postprandial carbohydrate metabolism in patients with non-insulin-dependent
diabetes mellitus. Results of randomized crossover trial. Diabetes October 1987 36:1130-1138; doi:10.2337/diabetes.36.10.1130
Loss of early phase of insulin release in humans impairs glucose tolerance and blunts thermic effect of glucose. Diabetes October 1987 36:1167-1172; doi:10.2337/diabetes.36.10.1167
Physiological role of cholecystokinin in meal-induced insulin secretion in conscious rats. Studies with L 364718, a specific
inhibitor of CCK-receptor binding. Diabetes October 1987 36:1212-1215; doi:10.2337/diabetes.36.10.1212
Prolactin enhances cell-to-cell communication among beta-cells in pancreatic islets. Diabetes October 1987 36:1098-1103; doi:10.2337/diabetes.36.10.1098
Physiological role of cholecystokinin in meal-induced insulin secretion in conscious rats. Studies with L 364718, a specific
inhibitor of CCK-receptor binding. Diabetes October 1987 36:1212-1215; doi:10.2337/diabetes.36.10.1212
Subunit structure, autophosphorylation, and tyrosine-specific protein kinase activity of hepatic insulin receptors in fetal,
neonatal, and adult rats. Diabetes October 1987 36:1161-1166; doi:10.2337/diabetes.36.10.1161
Prolactin enhances cell-to-cell communication among beta-cells in pancreatic islets. Diabetes October 1987 36:1098-1103; doi:10.2337/diabetes.36.10.1098
Effect of IgG subclasses on in vivo bioavailability and metabolic fate of immune-complexed insulin in Lewis rats. Diabetes October 1987 36:1144-1151; doi:10.2337/diabetes.36.10.1144
Effect of IgG subclasses on in vivo bioavailability and metabolic fate of immune-complexed insulin in Lewis rats. Diabetes October 1987 36:1144-1151; doi:10.2337/diabetes.36.10.1144
Adoptive transfer of insulitis and diabetes in neonates of diabetes-prone and -resistant rats. Tissue localization of injected
blasts. Diabetes October 1987 36:1116-1123; doi:10.2337/diabetes.36.10.1116
Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics. Diabetes October 1987 36:1195-1202; doi:10.2337/diabetes.36.10.1195
Effects of fasting on plasma glucose and prolonged tracer measurement of hepatic glucose output in NIDDM. Diabetes October 1987 36:1187-1194; doi:10.2337/diabetes.36.10.1187
Physiological role of cholecystokinin in meal-induced insulin secretion in conscious rats. Studies with L 364718, a specific
inhibitor of CCK-receptor binding. Diabetes October 1987 36:1212-1215; doi:10.2337/diabetes.36.10.1212